论文信息 - First and Second Trimester Screening - 字舞流文

First and Second Trimester Screening

M. Mahoney | M. Dimaio | J. Fox

[1] J. Haddow,et al. Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith–Lemli–Opitz syndrome (SLOS) , 2007, American journal of medical genetics. Part A.

[2] Y. Ville,et al. Long-term outcome of children born after a first-trimester measurement of nuchal translucency at the 99th percentile or greater with normal karyotype: a prospective study. , 2007, American journal of obstetrics and gynecology.

[3] K. Nicolaides,et al. Increased nuchal translucency with normal karyotype. , 2005, American journal of obstetrics and gynecology.

[4] C. Norem,et al. Maternal Serum Unconjugated Estriol as a Predictor for Smith–Lemli–Opitz Syndrome and Other Fetal Conditions , 2003, Obstetrics and gynecology.

[5] J. Haddow,et al. Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome , 2002, Journal of medical screening.

[6] B. Crandall,et al. Risks associated with an elevated amniotic fluid α-fetoprotein level , 1991 .

[7] B. Crandall,et al. Routine amniotic fluid alphafetoprotein assay: experience with 40,000 pregnancies. , 1986, American journal of medical genetics.